Log in

Relevant bibliographies by topics / Structural valve deterioration / Journal articles

To see the other types of publications on this topic, follow the link: Structural valve deterioration.

Journal articles on the topic 'Structural valve deterioration'

Author: Grafiati

Published: 15 June 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Structural valve deterioration.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Foroutan, Farid, Gordon H. Guyatt, Catherine M. Otto, et al. "Structural valve deterioration after transcatheter aortic valve implantation." Heart 103, no. 23 (2017): 1899–905. http://dx.doi.org/10.1136/heartjnl-2017-311329.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Atkins, B. Zane, and Gabriel S. Aldea. "“Drilling Down” on Structural Valve Deterioration." Journal of the American College of Cardiology 72, no. 5 (2018): 586. http://dx.doi.org/10.1016/j.jacc.2018.04.080.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hernandez-Vaquero, Daniel, Rocio Diaz, Isaac Pascual, Jacobo Silva, and Cesar Moris. "Considerations When Evaluating Structural Valve Deterioration." Journal of the American College of Cardiology 72, no. 5 (2018): 586–87. http://dx.doi.org/10.1016/j.jacc.2018.04.081.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Werner, Paul, Jasmin Gritsch, Sabine Scherzer, et al. "Structural valve deterioration after aortic valve replacement with the Trifecta valve." Interactive CardioVascular and Thoracic Surgery 32, no. 1 (2020): 39–46. http://dx.doi.org/10.1093/icvts/ivaa236.

Full text

Abstract:

Abstract OBJECTIVES Despite promising short- and mid-term results for durability of the Trifecta valve, contradictory reports of early structural valve deterioration (SVD) do exist. We investigated the incidence of SVD after surgical aortic valve replacement (SAVR) with the Trifecta in our single-centre experience. METHODS Data of 347 consecutive patients (mean age 71.6 ± 9.5 years, 63.4% male) undergoing SAVR with the Trifecta between 2011 and 2017 were analysed. Clinical and echocardiographic reports were obtained with a median follow-up of 41 months (1114 patient years). RESULTS Isolated SA

APA, Harvard, Vancouver, ISO, and other styles

5

Kattach, Hassan, Clifford W. Barlow, and Sunil K. Ohri. "Structural valve deterioration of a pericardial bioprosthesis." JTCVS Open 9 (March 2022): 84–85. http://dx.doi.org/10.1016/j.xjon.2021.10.059.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Jamieson, WR Eric, Hilton Ling, Lawrence H. Burr, et al. "Carpentier-Edwards Bioprosthesis: Structural Deterioration by Age Groups." Asian Cardiovascular and Thoracic Annals 5, no. 4 (1997): 193–98. http://dx.doi.org/10.1177/021849239700500402.

Full text

Abstract:

The Carpentier-Edwards supra-annular porcine bioprosthesis (second generation prosthesis) was implanted in 2438 patients in 2482 operations between 1982 and 1992. The mean age of the population was 64 years with a range from 21 years to 89 years. There were 1334 aortic and 934 mitral valve replacements. The population was divided into five groups: 21 to 40 years (n = 132); 41 to 50 years (n = 189); 51 to 60 years (n = 454); 61 to 70 years (n = 849); and over 70 years (n = 858). There was no difference in sunival by valve position for age groups 21 to 40 years and 41 to 50 years. Sunival within

APA, Harvard, Vancouver, ISO, and other styles

7

Sénage, Thomas, Florence Gillaizeau, Thierry Le Tourneau, Basile Marie, Jean-Christian Roussel, and Yohann Foucher. "Structural valve deterioration of bioprosthetic aortic valves: An underestimated complication." Journal of Thoracic and Cardiovascular Surgery 157, no. 4 (2019): 1383–90. http://dx.doi.org/10.1016/j.jtcvs.2018.08.086.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Issa, Issa Farah, Steen Hvitfeldt Poulsen, Farhad Waziri, et al. "Structural valve deterioration in the Mitroflow biological heart valve prosthesis." European Journal of Cardio-Thoracic Surgery 53, no. 1 (2017): 136–42. http://dx.doi.org/10.1093/ejcts/ezx321.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Nardi, Paolo, Carlo Bassano, Antonio Pellegrino, and Giovanni Ruvolo. "Early structural valve deterioration of the Mitroflow biological valve prosthesis." European Journal of Cardio-Thoracic Surgery 54, no. 1 (2018): 200–201. http://dx.doi.org/10.1093/ejcts/ezy136.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Deutsch, Marcus-André, N. Patrick Mayr, Gerald Assmann, et al. "Structural Valve Deterioration 4 Years After Transcatheter Aortic Valve Replacement." Circulation 131, no. 7 (2015): 682–85. http://dx.doi.org/10.1161/circulationaha.114.013995.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Tang, Gilbert H. L., Isaac George, and Vinayak N. Bapat. "Structural Valve Deterioration in Surgical Versus Transcatheter Aortic Valve Replacement." Journal of the American College of Cardiology 73, no. 21 (2019): 2785. http://dx.doi.org/10.1016/j.jacc.2019.02.073.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Belhaj Soulami, Réda, Miguel Castro, Pascal Haigron, and Jean-Philippe Verhoye. "Structural valve deterioration does not alter tissue valves’ radiopaque landmarks: Implications for valve-in-valve therapy." Medical Hypotheses 127 (June 2019): 49–56. http://dx.doi.org/10.1016/j.mehy.2019.03.033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Sénage, Thomas, Thierry Le Tourneau, Yohann Foucher, et al. "Early Structural Valve Deterioration of Mitroflow Aortic Bioprosthesis." Circulation 130, no. 23 (2014): 2012–20. http://dx.doi.org/10.1161/circulationaha.114.010400.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Olivito, Silvio, Stéphanie Lalande, Francesco Nappi, et al. "Structural deterioration of the cryopreserved mitral homograft valve." Journal of Thoracic and Cardiovascular Surgery 144, no. 2 (2012): 313–20. http://dx.doi.org/10.1016/j.jtcvs.2011.06.041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Eric Jamieson, W. R., D. Craig Miller, Cary W. Akins, et al. "Pregnancy and bioprostheses: Influence on structural valve deterioration." Annals of Thoracic Surgery 60 (August 1995): S282—S287. http://dx.doi.org/10.1016/0003-4975(95)00308-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Baldeo, Candice, AbdulWahab Hritani, Cherisse Baldeo, and Robert Percy. "Does chemo-radiation predispose to structural valve deterioration?" International Journal of Cardiology 211 (May 2016): 53–54. http://dx.doi.org/10.1016/j.ijcard.2016.02.155.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Della Barbera, Mila, Elena Pettenazzo, Ugolino Livi, et al. "Structural valve deterioration and mode of failure of stentless bioprosthetic valves." Cardiovascular Pathology 51 (March 2021): 107301. http://dx.doi.org/10.1016/j.carpath.2020.107301.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Reul, Ross M., Mahesh K. Ramchandani, and Michael J. Reardon. "Transcatheter Aortic Valve-in-Valve Procedure in Patients with Bioprosthetic Structural Valve Deterioration." Methodist DeBakey Cardiovascular Journal 13, no. 3 (2017): 132. http://dx.doi.org/10.14797/mdcj-13-3-132.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Yamanaka, Shota, and Shuichiro Takanashi. "Early Structural Valve Deterioration of Tricuspid Pericardial Valve Caused by Native Valve Adhesion." Annals of Thoracic Surgery 109, no. 3 (2020): e175-e176. http://dx.doi.org/10.1016/j.athoracsur.2019.06.084.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Aoyagi, Shigeaki, Kei-ichiro Tayama, Teiji Okazaki, et al. "Structural Valve Deterioration in a Starr-Edwards Mitral Caged-Disk Valve Prosthesis." Circulation Journal 77, no. 1 (2013): 105–8. http://dx.doi.org/10.1253/circj.cj-12-0906.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Axtell, Andrea L., David C. Chang, Serguei Melnitchouk, et al. "Early structural valve deterioration and reoperation associated with the mitroflow aortic valve." Journal of Cardiac Surgery 33, no. 12 (2018): 778–86. http://dx.doi.org/10.1111/jocs.13953.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Cinelli, Michael, Leonard Schwartz, Jonathan Spagnola, et al. "Early Structural Deterioration of a Sutureless Bioprosthetic Aortic Valve." Cardiology Research 11, no. 2 (2020): 113–17. http://dx.doi.org/10.14740/cr1013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Grunkemeier, Gary L., W. R. Eric Jamieson, D. Craig Miller, and Albert Starr. "Actuarial versus actual risk of porcine structural valve deterioration." Journal of Thoracic and Cardiovascular Surgery 108, no. 4 (1994): 709–18. http://dx.doi.org/10.1016/s0022-5223(94)70298-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Kaneko, Tsuyoshi, Igor Gosev, Marzia Leacche, and John G. Byrne. "Early Structural Valve Deterioration of the Mitroflow Aortic Bioprosthesis." Circulation 130, no. 23 (2014): 1997–98. http://dx.doi.org/10.1161/circulationaha.114.013368.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Gennari, Marco, Gianluca Polvani, Mara Rubino, Francesco Arlati, Andrea Annoni, and Marco Agrifoglio. "Undiagnosed mitroflow bioprosthesis deformation causing early structural valve deterioration." General Thoracic and Cardiovascular Surgery 66, no. 9 (2017): 543–45. http://dx.doi.org/10.1007/s11748-017-0868-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Jamieson, W. R. Eric, and Alfred N. Gerein. "Mitroflow Pericardial Bioprosthesis: Experience to Seven Years." Asian Cardiovascular and Thoracic Annals 1, no. 3 (1993): 123–28. http://dx.doi.org/10.1177/021849239300100305.

Full text

Abstract:

Between 1983 and 1987, the Mitroflow pericardial prosthesis was implanted in 99 patients, ranging in age from 28 to 94 years (mean 62.8 years). Early mortality was 6.1% (6 patients), and late mortality was 4.8% per patient-year (22 patients). Total cumulative follow-up was 458 patient-years (mean 4.6 years). At 7 years, patient survival was 62% for aortic valve replacement and 63% for mitral valve replacement. The overall rate of valve-related complications was 7.4% per patient-year (34 events): thromboembolism, 2.8%; antithromboembolic-relatedhemorrhage, 1.1%; prosthetic valve endocarditis, 0

APA, Harvard, Vancouver, ISO, and other styles

27

Murashita, Takashi, David L. Joyce, Alberto Pochettino, John M. Stulak, and Lyle D. Joyce. "Concomitant Valve-In-Valve Transcatheter Aortic Valve Replacement and Left Ventricular Assist Device Implantation." Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 12, no. 2 (2017): 147–49. http://dx.doi.org/10.1097/imi.0000000000000360.

Full text

Abstract:

Redo aortic valve replacement (AVR) performed simultaneously with left ventricular assist device (LVAD) implantation carries potential for increased mortality rates. Although transcatheter AVR has been used for patients with previous LVAD placement, no literature reports concomitant valve-in-valve transcatheter AVR and LVAD implantation. Our patient had severe aortic prosthetic valve deterioration and advanced heart failure. Given the risks associated with reoperative aortic valve surgery, we chose transcatheter AVR at the time of LVAD implantation. Transthoracic echocardiography results showe

APA, Harvard, Vancouver, ISO, and other styles

28

Salaun, Erwan, Marie-Annick Clavel, Josep Rodés-Cabau, and Philippe Pibarot. "Bioprosthetic aortic valve durability in the era of transcatheter aortic valve implantation." Heart 104, no. 16 (2018): 1323–32. http://dx.doi.org/10.1136/heartjnl-2017-311582.

Full text

Abstract:

The main limitation of bioprosthetic valves is their limited durability, which exposes the patient to the risk of aortic valve reintervention. Transcatheter aortic valve implantation (TAVI) is considered a reasonable alternative to surgical aortic valve replacement (SAVR) in patients with intermediate or high surgical risk. TAVI is now rapidly expanding towards the lower risk populations. Although the results of midterm durability of the transcatheter bioprostheses are encouraging, their long-term durability remains largely unknown. The objective of this review article is to present the defini

APA, Harvard, Vancouver, ISO, and other styles

29

Kang, Yoonjin, Ho Young Hwang, Suk Ho Sohn, Jae Woong Choi, Kyung Hwan Kim, and Ki‐Bong Kim. "Comparative analysis of structural valve deterioration after bioprosthetic tricuspid valve replacement: Bovine pericardial versus porcine valves." Artificial Organs 45, no. 8 (2021): 911–18. http://dx.doi.org/10.1111/aor.13909.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Kuroda, Yuki, Akira Marui, Yoshio Arai, et al. "Impact of dialysis in patients undergoing bioprosthetic aortic valve replacement." Interactive CardioVascular and Thoracic Surgery 33, no. 3 (2021): 348–53. http://dx.doi.org/10.1093/icvts/ivab106.

Full text

Abstract:

Abstract OBJECTIVES To determine the incidence of bioprosthetic structural valve deterioration in dialysis patients undergoing aortic valve replacement compared to that in patients without dialysis. METHODS This single-centre retrospective observational study included 1159 patients who underwent aortic valve replacement using bioprosthetic valves for aortic stenosis and/or regurgitation at our institution between 2007 and 2017 [patients with dialysis (group D, n = 134, 12%) or without dialysis (group N, n = 1025, 88%)]. To adjust for potential differences between groups in terms of initial pre

APA, Harvard, Vancouver, ISO, and other styles

31

Kiefer, Philipp, Joerg Seeburger, Michael W. A. Chu, et al. "Reoperative Transapical Aortic Valve Implantation for Early Structural Valve Deterioration of a SAPIEN XT valve." Annals of Thoracic Surgery 95, no. 6 (2013): 2169–70. http://dx.doi.org/10.1016/j.athoracsur.2012.10.072.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Takano, Tamaki, Tatsuichiro Seto, Shiho Asaka, et al. "Structural Valve Deterioration of Porcine Bioprosthesis Soon after Mitral Valve Repair and Replacement." Annals of Thoracic and Cardiovascular Surgery 20, Supplement (2014): 717–19. http://dx.doi.org/10.5761/atcs.cr.13.02264.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Nappi, Francesco, Cristiano Spadaccio, Massimo Chello, Mario Lusini, and Cristophe Acar. "Impact of Structural Valve Deterioration on Outcomes in the Cryopreserved Mitral Homograft Valve." Journal of Cardiac Surgery 29, no. 5 (2014): 616–22. http://dx.doi.org/10.1111/jocs.12400.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Zakko, J., N. Matre, R. Tamer, et al. "EARLIER STRUCTURAL VALVE DETERIORATION AND TIME TO REOPERATION IN AN EXTERNALLY WRAPPED VALVE." Canadian Journal of Cardiology 39, no. 10 (2023): S191. http://dx.doi.org/10.1016/j.cjca.2023.06.293.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Zakko, J., N. Matre, R. Tamer, et al. "EARLIER STRUCTURAL VALVE DETERIORATION AND TIME TO REOPERATION IN AN EXTERNALLY WRAPPED VALVE." Canadian Journal of Diabetes 47, no. 7 (2023): S157—S158. http://dx.doi.org/10.1016/j.jcjd.2023.10.296.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Emir, Mustafa, Gürkan Uzunonat, Birol Yamak, et al. "Effects of Pregnancy on Long-Term Follow-Up of Mitral Valve Bioprostheses." Asian Cardiovascular and Thoracic Annals 6, no. 3 (1998): 174–78. http://dx.doi.org/10.1177/021849239800600306.

Full text

Abstract:

Between 1986 and 1990, 304 females between 11 and 45 (mean, 33.9 ± 6.9) years of age underwent isolated mitral valve replacement with a bioprosthesis. Thirty-nine of the 285 survivors experienced 48 pregnancies during the late follow-up period (group 1). Structural valve deterioration occurred in 25 (64.1%) of these patients and in 70 (28.4%) of the 246 patients (group 2) who did not become pregnant (p < 0.01). The mean time at which structural valve deterioration occurred was 7.01 ± 1.19 years postoperatively (range, 4.74 to 8.36 years) for group 1 patients and 6.76 ± 1.34 years (range, 2.

APA, Harvard, Vancouver, ISO, and other styles

37

Rheude, Tobias, Costanza Pellegrini, Salvatore Cassese, et al. "Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves." EuroIntervention 15, no. 14 (2020): 1233–39. http://dx.doi.org/10.4244/eij-d-19-00710.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Lobov, A., A. N. Kostyunin, T. V. Glushkova, et al. "Proteomic profiling reveals unique signatures of structural bioprosthetic valve deterioration." Atherosclerosis 355 (August 2022): 41–42. http://dx.doi.org/10.1016/j.atherosclerosis.2022.06.349.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Hayatsu, Yukihiro, Takeshi Saito, Osamu Adachi, et al. "Reoperation on a Starr–Edwards ball valve without structural deterioration." General Thoracic and Cardiovascular Surgery 60, no. 12 (2012): 827–29. http://dx.doi.org/10.1007/s11748-012-0092-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Galiñanes, Manuel, Kelly Casós, Arnau Blasco-Lucas, et al. "Oxidative Stress in Structural Valve Deterioration: A Longitudinal Clinical Study." Biomolecules 12, no. 11 (2022): 1606. http://dx.doi.org/10.3390/biom12111606.

Full text

Abstract:

The cause of structural valve deterioration (SVD) is unclear. Therefore, we investigated oxidative stress markers in sera from patients with bioprosthetic heart valves (BHVs) and their association with SVD. Blood samples were taken from SVD (Phase A) and BHV patients during the first 24 (Phase B1) and >48 months (Phase B2) after BHV implantation to assess total antioxidant capacity (TAC), malondialdehyde (MDA), and nitrotyrosine (NT). The results show that MDA levels increased significantly 1 month after surgery in all groups but were higher at 6 months only in incipient SVD patients. NT le

APA, Harvard, Vancouver, ISO, and other styles

41

Van Belle, Eric, Cédric Delhaye, and Flavien Vincent. "Structural Valve Deterioration at 5 Years of TAVR Versus SAVR." Journal of the American College of Cardiology 76, no. 16 (2020): 1844–47. http://dx.doi.org/10.1016/j.jacc.2020.09.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Li, Fei, Xu Wang, Yuetang Wang, et al. "Structural Valve Deterioration after Transcatheter Aortic Valve Implantation Using J-Valve: A Long-Term Follow-Up." Annals of Thoracic and Cardiovascular Surgery 26, no. 3 (2020): 158–65. http://dx.doi.org/10.5761/atcs.oa.19-00325.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Stankowski, Tomasz, Sleiman Sebastian Aboul-Hassan, Farzaneh Seifi-Zinab, et al. "Severe structural deterioration of small aortic bioprostheses treated with valve-in-valve transcatheter aortic valve implantation." Journal of Cardiac Surgery 34, no. 1 (2019): 7–13. http://dx.doi.org/10.1111/jocs.13976.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Wongkornrat, Wanchai, Kornkan Mahasawas, Punnarerk Thongcharoen, and Thaworn Subtaweesin. "Long Term Outcomes and Durability of Bioprosthetic Valve for Valve Replacement at Siriraj Hospital." Siriraj Medical Journal 74, no. 4 (2022): 211–16. http://dx.doi.org/10.33192/smj.2022.26.

Full text

Abstract:

Objective: Bioprosthesis has been used in cardiac valve replacement for a long time. However, structural valve deterioration is still a major cause of failure. There are several risk factors for valve deterioration. This study evaluates the risk factors of valve deterioration in the long term (10 years) at Siriraj Hospital.Materials and Methods: We retrospectively reviewed the medical records of 249 patients who underwent mitral or aortic valve replacement between January 2006 and December 2012 using various tissue valves, comprising Carpentier–Edwards porcine, Carpentier–Edwards Perimount bov

APA, Harvard, Vancouver, ISO, and other styles

45

Edelman, J. James, Jaffar M. Khan, Toby Rogers, et al. "Valve-in-Valve TAVR: State-of-the-Art Review." Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery 14, no. 4 (2019): 299–310. http://dx.doi.org/10.1177/1556984519858020.

Full text

Abstract:

An increasing number of surgically implanted bioprostheses will require re-intervention for structural valve deterioration. Valve-in-valve transcatheter aortic valve replacement (ViV TAVR) has become an alternative to reoperative surgery, currently approved for high-risk and inoperable patients. Challenges to the technique include higher rates of prosthesis–patient mismatch and coronary obstruction, compared to native valve TAVR. Herein, we review results of ViV TAVR and novel techniques to overcome the aforementioned challenges.

APA, Harvard, Vancouver, ISO, and other styles

46

Schamroth Pravda, Nili, Hana Vaknin Assa, Amos Levi, et al. "Tricuspid Structural Valve Deterioration Treated with a Transcatheter Valve-in-Valve Implantation: A Single-Center Prospective Registry." Journal of Clinical Medicine 11, no. 9 (2022): 2667. http://dx.doi.org/10.3390/jcm11092667.

Full text

Abstract:

The valve-in-valve (ViV) technique is an emerging alternative for the treatment of bioprosthetic structural valve deterioration (SVD) in the tricuspid position. We report on the outcomes of patients treated by a transcatheter tricuspid valve-in-valve (TT-ViV) implantation for symptomatic SVD in the tricuspid position during the years 2010–2019 at our center. Three main outcomes were examined during the follow-up period: TT-ViV hemodynamic data per echocardiography, mortality and NYHA functional class. Our cohort consisted of 12 patients with a mean age 65.4 ± 11.9 years, 83.3% male. The mean t

APA, Harvard, Vancouver, ISO, and other styles

47

Watanabe, Tatsuya, Noriyuki Tokunaga, Keita Maruno, Hideo Yoshida, and Masahiko Kuinose. "Redo aortic valve replacement due to early structural valve deterioration in a trifecta valve: A case report." International Journal of Surgery Case Reports 86 (September 2021): 106381. http://dx.doi.org/10.1016/j.ijscr.2021.106381.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Angelillis, Marco. "A valve-in-valve transcatheter aortic valve implantation with commissural alignment using advanced imaging reconstruction: a case report." Clinical Cardiology and Cardiovascular Interventions 3, no. 10 (2020): 01–05. http://dx.doi.org/10.31579/2641-0419/090.

Full text

Abstract:

Transcatheter valve in valve (ViV) implantation actually represents a valid alternative to surgical reinterventions in patients with previous surgical aortic valve replacement (AVR). In patients less than 80 years old, it is crucial to correctly position the new valve leaving a feasible and easy access to coronary ostia, both for future percutaneous coronary intervention (PCI) than for a future possible TAVinTAV procedure. We report a 71 year old man with prior AVR presented with structural valve deterioration (SVD) leading to severe aortic stenosis. In order to guarantee comfortable coronary

APA, Harvard, Vancouver, ISO, and other styles

49

Kotani, Mitsuhisa, Masaaki Toyama, Masanori Katoh, Yuji Kato, Kazuhiro Hisamoto, and Yukiharu Sugimura. "Early Structural Valve Deterioration of Third-Generation Porcine Bioprosthesis in Patients." Japanese Journal of Cardiovascular Surgery 39, no. 6 (2010): 339–42. http://dx.doi.org/10.4326/jjcvs.39.339.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Koizumi, Shintaroh, Kaoru Matsuura, Yoshio Kobayashi, and Goro Matsumiya. "Low-gradient structural valve deterioration in a patient of cardiac sarcoidosis." Journal of Cardiovascular Echography 27, no. 2 (2017): 59. http://dx.doi.org/10.4103/jcecho.jcecho_47_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!